RI
RTW Investments’s Relmada Therapeutics RLMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,131,835
| Closed | -$6.4M | – | 72 |
|
|
2023
Q3 | $6.4M | Hold |
2,131,835
| – | – | 0.13% | 52 |
|
|
2023
Q2 | $5.24M | Hold |
2,131,835
| – | – | 0.1% | 56 |
|
|
2023
Q1 | $4.82M | Buy |
2,131,835
+64,011
| +3% | +$145K | 0.1% | 51 |
|
|
2022
Q4 | $7.22M | Sell |
2,067,824
-576,651
| -22% | -$2.01M | 0.15% | 54 |
|
|
2022
Q3 | $97.9M | Buy |
2,644,475
+6,894
| +0.3% | +$255K | 2.26% | 14 |
|
|
2022
Q2 | $50.1M | Buy |
2,637,581
+97,507
| +4% | +$1.85M | 1.29% | 27 |
|
|
2022
Q1 | $68.6M | Buy |
2,540,074
+353,750
| +16% | +$9.55M | 1.42% | 27 |
|
|
2021
Q4 | $49.3M | Buy |
2,186,324
+648,298
| +42% | +$14.6M | 0.72% | 44 |
|
|
2021
Q3 | $40.3M | Hold |
1,538,026
| – | – | 0.61% | 46 |
|
|
2021
Q2 | $49.2M | Buy |
1,538,026
+7,309
| +0.5% | +$234K | 0.74% | 35 |
|
|
2021
Q1 | $53.9M | Buy |
1,530,717
+18,044
| +1% | +$635K | 0.84% | 35 |
|
|
2020
Q4 | $48.5M | Buy |
1,512,673
+1,336
| +0.1% | +$42.8K | 0.81% | 35 |
|
|
2020
Q3 | $56.9M | Buy |
1,511,337
+30,485
| +2% | +$1.15M | 1.37% | 21 |
|
|
2020
Q2 | $66.3M | Buy |
1,480,852
+496,310
| +50% | +$22.2M | 1.86% | 17 |
|
|
2020
Q1 | $33.6M | Buy |
984,542
+320,058
| +48% | +$10.9M | 1.45% | 25 |
|
|
2019
Q4 | $25.9M | Buy |
+664,484
| New | +$25.9M | 0.98% | 28 |
|